TY - JOUR
T1 - Alterations in immune function following head injury in children
AU - Meert, K. L.
AU - Long, M.
AU - Kaplan, J.
AU - Sarnaik, A. P.
PY - 1995
Y1 - 1995
N2 - Objective: To investigate cellular and humoral immunity in children immediately after severe head injury and during the early recovery period. Design: Prospective, observational study with factorial design. Setting: Pediatric ICU of a university teaching hospital. Patients: Fifteen children (median age 9.6 yrs, range 1.7 to 18) with head injury and Glasgow Coma Score of ≤7. Interventions: None. Measurements and Main Results: Skin testing with seven standard antigens was performed and blood samples were obtained for the following measurements: total lymphocyte count and subsets; proliferative response to phytohemagglutinin, concanavalin A, and pokeweed mitogen; and immunoglobulin concentrations on days 1, 7, and 14 and 3 months after injury. The effect of patient plasma on phytohemagglutinin-induced proliferative responses of normal donor lymphocytes was also assessed at these times. Anergy was present in 71% of patients on day 1, 54% of patients on day 7, 31% of patients on day 14, and 18% of patients at 3 months. Total, helper, and suppressor T-cell counts were decreased on day 1, and the T-cell response to phytohemagglutinin was decreased on days 1, 7, and 14 compared with values at 3 months. B-cell counts were increased on day 1, followed by an increase in serum immunoglobulin concentrations 1 to 2 wks later. The B-cell response to pokeweed mitogen was unchanged over the 3-month study period. The phytohemagglutinin responses of normal donor lymphocytes were decreased when incubated with patient plasma obtained on day 7 after injury. Conclusions: Severe head injury in children is associated with depressed cell-mediated immunity. Plasma immunosuppressive factors may contribute to T-cell dysfunction.
AB - Objective: To investigate cellular and humoral immunity in children immediately after severe head injury and during the early recovery period. Design: Prospective, observational study with factorial design. Setting: Pediatric ICU of a university teaching hospital. Patients: Fifteen children (median age 9.6 yrs, range 1.7 to 18) with head injury and Glasgow Coma Score of ≤7. Interventions: None. Measurements and Main Results: Skin testing with seven standard antigens was performed and blood samples were obtained for the following measurements: total lymphocyte count and subsets; proliferative response to phytohemagglutinin, concanavalin A, and pokeweed mitogen; and immunoglobulin concentrations on days 1, 7, and 14 and 3 months after injury. The effect of patient plasma on phytohemagglutinin-induced proliferative responses of normal donor lymphocytes was also assessed at these times. Anergy was present in 71% of patients on day 1, 54% of patients on day 7, 31% of patients on day 14, and 18% of patients at 3 months. Total, helper, and suppressor T-cell counts were decreased on day 1, and the T-cell response to phytohemagglutinin was decreased on days 1, 7, and 14 compared with values at 3 months. B-cell counts were increased on day 1, followed by an increase in serum immunoglobulin concentrations 1 to 2 wks later. The B-cell response to pokeweed mitogen was unchanged over the 3-month study period. The phytohemagglutinin responses of normal donor lymphocytes were decreased when incubated with patient plasma obtained on day 7 after injury. Conclusions: Severe head injury in children is associated with depressed cell-mediated immunity. Plasma immunosuppressive factors may contribute to T-cell dysfunction.
KW - B cells
KW - T cells
KW - critical illness
KW - head injury
KW - immunity
KW - immunoglobulin
KW - immunosupppression
KW - infection
KW - lymphocytes
KW - mitogens
KW - neurologic emergencies
UR - http://www.scopus.com/inward/record.url?scp=0029036016&partnerID=8YFLogxK
U2 - 10.1097/00003246-199505000-00008
DO - 10.1097/00003246-199505000-00008
M3 - Article
C2 - 7736738
AN - SCOPUS:0029036016
SN - 0090-3493
VL - 23
SP - 822
EP - 828
JO - Critical Care Medicine
JF - Critical Care Medicine
IS - 5
ER -